TSANZ home

Results for "empyema"

Home 5 Search query for: empyema
Results for "empyema"
VOLUME 4.02 APRIL 2019

VOLUME 4.02 APRIL 2019

Research Roundup:

April 2019

.
 

Welcome Message

The TSANZSRS19 was a great success and we thank all delegates and exhibitors for supporting respiratory research and professional development once again.

At TSANZSRS19 respiratory research received a much needed boost of funding from TSANZ, LFA, CFA, NAC, and our partners. These awards were announced at the Respiratory Research Excellence Awards session and the Gala Dinner. Please find a re-cap of all the Thoracic Society Board Awards and Research Awards below, including the winners of the Special Interest Group Awards.

During the conference we opened a number of larger TSANZ awards, namely the AstraZeneca Respiratory Research Fellowships, which will support one early-career researcher and one mid-career researcher and the Vertex Cystic Fibrosis Research Awards, which will support one adult CF research project and one paediatric CF research project. There are also opportunities for IPF PhD scholarships and Menarini travel awards from the Lung Foundation. Links to these awards can be found in the Open Awards section below.

Enjoy the April edition of your research roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

$1 MILLION FOR LUNG DISEASE RESEARCH ANNOUNCED

Top lung health bodies raise much needed funds but more investment needed

(Thursday, 8th April 2019): Over a million dollars in lung research investment was announced over the weekend at the Respiratory Research Excellence Awards at the Australia and New Zealand Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science(TSANZSRS19) on the Gold Coast. The conference brings together Australia and New Zealand’s leading lung health experts to present latest research and improve knowledge and understanding of lung disease.

The Research Excellence Awards, run for the second year by Thoracic Society of Australia and New Zealand (TSANZ) – the hosts of the conference – alongside the Lung Foundation, Cystic Fibrosis Australia and the National Asthma Council of Australia, provides over 40 researchers with support in the form of project funding, fellowships and travel grants raised through private donations, sponsorship and leveraged financing from recipients’ institutions.

“We’re honoured to be able to support some of Australia’s greatest minds in lung disease research; research that’s making a difference to the lives of the 1 in 4 Australians with lung disease,” said TSANZ President Elect Professor Bruce Thompson.

“This funding enables our researchers to build respiratory knowledge and capacity in the respiratory workforce, with the overall goal of preventing, curing and alleviating disability from lung disease. Every dollar invested takes us one step closer to reaching that goal,” he said.

Despite the success of the Awards, the organisers warn that lung disease research is still grossly underfunded when compared to other diseases. Far more investment is required, they say.

“It’s important to recognise the exceedingly hard work that our organisations are putting in to raising the profile of respiratory research, and to express our thanks for the contribution of donors, sponsors and institutions This is only our second year and look at what we’ve achieved,” said TSANZ CEO Tanya Buchanan.

“However, fundraising alone is not the way to manage diseases affecting a quarter of Australians. Lung disease has to attract the same level of research funding enjoyed by other disease areas such as breast, prostate, and heart disease. We look forward to seeing if the implementation of the National Strategic Action Plan for Lung Conditions delivers this,” she said.

2019 RESPIRATORY RESEARCH EXCELLENCE AWARD WINNERS

TSANZ would like to congratulate the following Award winners. For information on how to apply for next year’s Awards visit the TSANZ website Research and Awards page.

Society Medal

Professor Helen Reddel

Research Medal

Professor Philip Hansbro

Laennec Medal

Professor Allan R Glanville

Ann Woolcock New Investigator Award

Jesse Armitage

Best training Video

Elizabeth Salamon, Selena West, Ursula Swan, Sandra Daly

CSL Behring TSANZ / LFA Alpha-1 Anti-trypsin Deficiency Research Award

Gang Liu

Australian Cystic Fibrosis Research Trust Innovation Grant

Gerard Kaiko, Peter Wark, Shafagh Water, and Adam Jaffe

TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship

Kimberly Wang

Boehringer Ingelheim COPD Research Award 2019

Tatt Jhong Haw

Maurice Blackburn Grant-in-Aid for Occupational Lung Disease

Jane Bourke and Ryan Hoy

Boston Scientific Research Award for Interventional Pulmonology

Sanjeevan Muruganandan

Vertex Cystic Fibrosis Research Awards

ECFS: Elena Schneider-Futschik

NACFC: Rebecca Stockwell

TSANZ Peter Phelan Research Award

Elena Schneider-Futschik

TSANZ Rob Pierce Grant-In-Aid for Indigenous Lung Health

Gabrielle McCallum

TSANZ / Boehringer Ingelheim Australia COPD Travel Award

Alen Faiz

TSANZ / Boehringer Ingelheim New Zealand COPD Travel Award

Eskandarain Shafuddin

TSANZ/JRS Early Career Development Award

Jemma Seyfang

Janet Elder International Travel Awards

Mid-Career Award Recipient: Kimberley Wang

Early Career Award Recipient 1: Vikas Goyal

Early Career Award Recipient 2: Yet H Khor

TSANZ Respiratory Nurse Career Development Award for Indigenous Research

Betty Poot

Christine Sullivan

Maurice Blackburn ASM Travel Award

Leona Dowman

Shine a light a lung cancer PhD 2019

Kanishka Rangamuwa

David Wilson PhD Scholarship in Idiopathic Pulmonary Fibrosis Research 2019

Archana Gaikwad

Shine a light on lung cancer grant-in-aid

Surein Arulananda

Lung Foundation Australia/ Eleanor Greenwood Memorial Grant in Aid for Interstitial Lung Disease Research

Yet Hong Khor

Lung Foundation Australia /Lizotte Family Research Award for Interstitial PF Research

Leona Dowman

Lung Foundation Australia /Ludwig Engel GIA for Physiological research

Katrina Tonga

Lung Foundation Australia /Ivan Cash Research GIA – IPF

Adelle Jee

Lung Foundation Australia /Cochrane

Jenifer Liang

Shine a light on lung cancer nursing/allied health fellowship in lung cancer research

Vanessa Brunelli

Lung Foundation Australia Travel Awards: Menarini Travel Grants

ERS – Hannah O’Farrell and Jack Bozier

ATS – Thomas Altree and Razia Zakarya

APSR – Leanne Ross and Hai Bac Tran

Lung Foundation Australia/Eleanor Greenwood Memorial ILD Travel Grant

Cecilia Prele

Michael Schuliga

Jade Jaffar

 

SIG AWARDS

Supported by TSANZ

Cell, Immunology and Molecular Biology: Dhammika Leshan

Evidence-based Medicine and Practice: Yet Hong Khor

Peter van Asperen Paediatric: Kiara Sclip

Physiotherapy: Jamie Wood

Respiratory Infectious Disease: Benjamin Diggins

Tobacco: Henry Gomez

Supported by Asthma Australia

Asthma & Allergy: Teresa Williams

Supported by National Asthma Council

Asthma & Allergy : Cherry Thompson

Supported by Lung Foundation Australia

Pulmonary Physiology and Sleep, John Reid Prize: Graeme Zosky

David Serisier Memorial Award for Translational Research in Bronchiectasis: Su Wei Khung

Supported by Cystic Fibrosis Australia

Cystic Fibrosis: Elena Schneider-Futschik

Supported by Maurice Blackburn

Lung Cancer: Lara Edbrooke

Occ Env Lung Disease / Population Health: Edward Harris

Palliative Care and Symptom Support: Thomas Moran

Supported by Carroll & O’Dea

Interventional Pulmonology and Bronchoscopy: Deirdre Fitzgerald

Supported by Boehringer Ingelheim

Orphan Lung Diseases, Lung Transplant, Interstitial Lung Disease and Pulmonary Vascular Disease: Jemma Seyfang

Primary Care: Mary Roberts

Chronic Obstructive Pulmonary Disease: Sonia Cheng

Respiratory Nurses: Jane Neil

TSANZ Best Poster: Kris Nilsen: A new tool to monitor disease in IPF

CONGRATULATIONS TO…

TSANZ would also like to take this opportunity to congratulate the following New Fellows for 2019:

  • Prof Anne Holland
  • Dr Denise O’Driscoll
  • Dr Jane Bourke
  • A/Prof Jeff Garrett
  • Prof Paul Foster
  • Prof Peter Eastwood
  • Prof Sandra Hodge

 

Open Awards

Thoracic Society Awards

AstraZeneca Respiratory Research Fellowships – closes 2nd June 2019

Vertex Adult Cystic Fibrosis Research Award – closes 2nd June 2019

Vertex Paediatric Cystic Fibrosis Research Award – closes 2nd June 2019

Lung Foundation Awards

Lung Foundation Australia Brian Eaton Memorial PhD Scholarship in IPF – closes 10th June 2019

Lung Foundation Australia Diana Cox PhD Scholarship in IPF – closes 10th June 2019

Lung Foundation Australia / A Menarini Pty Ltd 2019 Travel Awards 

Travel application deadlines

ATS: 22nd March 2019 (5pm AEST)

ERS: 31st July 2019 (5pm AEST)

APSR: 13th September 2019 (5pm AEST)

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

Respirology – Editor’s Choice

Respirology Issue 24.4 2019

Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis Registry

Helen E. Jo, Ian Glaspole, Nicole Goh, Peter M.A. Hopkins, Yuben Moodley, Paul N. Reynolds, Sally Chapman, Eugene Haydn Walters, Christopher Zappala, Heather Allan, Sacha Macansh, Christopher Grainge, Gregory J. Keir, Andrew Hayen, Douglas Henderson, Sonja Klebe, Stefan B. Heinze, Anne Miller, Hannah C. Rouse, Edwina Duhig, Wendy A. Cooper, Annabelle M. Mahar, Samantha Ellis, Samuel R. McCormack, Bernard Ng, David B. Godbolt, Tamera J. Corte

DOI: 10.1111/resp.13427 

Distribution of participants in the Australian IPF Registry

 

A consensus opinion amongst stakeholders as to benefits of obstructive sleep apnoea treatment for cardiovascular health

Shane A. Landry, Siobhan Banks, Peter A. Cistulli, Garun S. Hamilton, Laure Héraud, Kristina Kairaitis, Steven Lubke, Sutapa Mukherjee, Teanau Roebuck, Joesph Soda, Darren Umbers, Shantha M. W. Rajaratnam, Darren Mansfield.

DOI: 10.1111/resp.13413

 

From left to right: Prof Shantha Rajaratnam, Dr Shane Landry, A/Prof Darren Mansfield from Monash University and the Monash Medical Centre in Melbourne, Australia

Research Project and Survey Requests

Current Opinions of Severe Asthma Specialists on the Utility of Biomarkers for the Management of Corticosteroid Treatment: A Survey

If you are an Australian clinician involved in the care of patients with severe asthma, we would be very grateful if you could complete a brief questionnaire.

We would ideally like to sample opinions from specialists involved in the care and management of patients with severe asthma to reach consensus. This is the second round of a multi-national Delphi process to reach a consensus and there may be follow-up questions based on the answers we receive from this round (with likely 2-3 rounds in total).

A strategy to optimize corticosteroid use in the severe asthma population using biomarkers is currently being investigated. Professors Peter Wark and Jodie Simpson at the University of Newcastle, Australia are looking at an algorithm to adjust corticosteroid dose using exhaled nitric oxide (FeNO), and peripheral blood eosinophils. This survey is being conducted by them, and will also be part of a Masters by Research by Dr. James Michael Ramsahai. As part of this project, we would like to seek your views on some aspects of biomarker based corticosteroid adjustment in severe asthma.

For more details, please see the attached information statement. Please note that completion of the survey will imply consent to participate, and for the data collected to be used for analysis. You may withdraw at any time.

If you agree to participate, please follow the link to complete the survey

http://selectsurvey.hnehealth.nsw.gov.au/TakeSurvey.aspx?SurveyID=78M2nn61

*for issues with the survey link, please try copying and pasting into your browser and/or using Firefox browser. Feel free to contact the investigators with any questions*

Thank you,

Peter Wark
Jodie Simpson
J. Michael Ramsahai
 JamesMichael.Ramsahai@uon.edu.au

 

Survey of Attitudes of Australian Specialists to Lung Cancer Screening with Low Dose Computed Tomography

To Members of the Thoracic Society of Australia and New Zealand,

Lung cancer screening with low dose computed tomography has been implemented overseas however is still a debated topic within Australia. We are conducting a survey of Australian specialists and their knowledge and attitudes towards lung cancer screening and perceived barriers to the implementation of lung cancer screening with low dose computed tomography within Australia.

The anonymous survey is available online using the SurveyMonkey survey tool and takes approximately 7 minutes to complete.  It can be accessed via the following link.  https://www.surveymonkey.com/r/AttitudesToLDCT

Please don’t hesitate to contact us if you require any further information.  We attach our study protocol and copy of HREC approval (The Prince Charles Hospital Human Research and Ethics Committee LNR/2018/QPCH/44970).

Thank you for your kind support.

Yours truly

Rachel McLellan, Advanced RACP Trainee
Kwun Fong
Henry Marshall
Rayleen Bowman
Ian Yang

University of Queensland Thoracic Research Centre at The Prince Charles Hospital
Metro North Hospital and Health Service | Queensland Government
Rode Road, Chermside, Brisbane QLD 4032, AUSTRALIA
t. 61 7 [31394000] e. ILST@health.qld.gov.au | www.health.qld.gov.au

 

 

New survey about Victorian doctors’ end-of-life decision-making

Victorian doctors in specialties likely to be involved in end-of-life decisions are being surveyed about their decision-making practices involving adult patients. Researchers from the NHMRC-funded Centre of Research Excellence in End-of-Life Care are conducting a study to determine what sort of end-of-life decisions are being made by doctors, how often these decisions occur and for what sort of patients.

At present, there are no up-to-date, representative Australian data describing the frequency and nature of medical end-of-life decisions involving adults, and the characteristics of patients about whom such decisions are made. The research aims to provide an evidence base to understand current medical practice in Victoria including the extent to which palliative care is provided to patients at the end of life. Findings from this research will also inform improvements in the quality of end-of-life care.

A sample of Victorian doctors will be contacted in April and May by the AMA’s Australia Medical Publishing Company (AMPCo) to invite them to complete a survey.  The survey can be completed in hard copy or online.  Participating doctors who complete their survey before 16 May will go into the draw for one of three prizes to the value $100, in fine wine, or a donation to a registered charity of your choice.

If you have any queries about this research, please feel free to contact Dr Rachel Feeney[rachel.feeney@qut.edu.au]. The research team is grateful for the time and insight of the doctors who support this research by completing this survey.

 

Management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics

Dear TSANZ Member,

You are invited to participate in a survey that is being conducted as part of a research study. The following survey asks a series of questions about your current practice, specifically with regards to the management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics. Insights gained will be considered for future presentation and publication. The estimated time to complete the survey is 10 minutes. Partial responses will not be saved if you exit out the survey early. Your participation is voluntary and anonymous. Responses will be kept confidential. Your contribution is greatly appreciated.

The survey can be completed here: https://hms.az1.qualtrics.com/jfe/form/SV_8ddQsXRFwaqAtPD

If you have any questions about the survey, please contact the study team at: vholden@som.umaryland.edu

We thank you in advance for your participation.

Sincerely,

Van Holden, MD
Mihir Parikh, MD
Alex Chee, MD
Adnan Majid, MD

Division of Thoracic Surgery & Interventional Pulmonology
Beth Israel Deaconess Medical Center
Harvard Medical School

The attached survey has been approved by the Beth Israel Deaconess Institutional Review Board – The IRB Protocol # is 2018P000052.

 
 

.

VOLUME 4.02 APRIL 2019

VOLUME 4.01 MARCH 2019

Research Roundup:

March 2019

.
 

Welcome Message

The TSANZSRS19 is just around the corner, coming up in just 3 short weeks! This year’s theme is respiratory infection and will showcase plenary sessions such as How infections and microbiomes influence respiratory disease, Microbial pathogenesis in chronic lung disease, and the ANZSRS/TSANZ joint plenary on Bugs behaving badly. The theme even extends into the TSANZ Gala Dinner, inviting delegates to come dressed as their choice of superhero or superbug! Visit the conference website for the full program or to register now.

We would like to remind everyone that this year we will once again be holding the Respiratory Research Excellence Awards and you are all invited and encouraged to attend! This event drew a full house last year as we all gathered to support, thank and congratulate our colleagues, collaborators, and sponsors. Please pick up a glass of bubbles at the door and join us again for this opening event.

We wish you all the best in your preparation for the ASM. See you on the Gold Coast.

Enjoy the March edition of your research roundup and please check out the surveys below.

Profs Phil Hansbro & Sandra Hodge

Co-Chairs, Research Sub-Committee

 

Open Awards

Lung Foundation Awards

Lung Foundation Australia / A Menarini Pty Ltd 2019 Travel Awards 

Travel application deadlines

ATS: 22nd March 2019 (5pm AEST)

ERS: 31st July 2019 (5pm AEST)

APSR: 13th September 2019 (5pm AEST)

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

Respirology – Editor’s Choice

Respirology Issues 2019

Treatable traits can be identified in a severe asthma registry and predict future exacerbations

Vanessa M. McDonald, Sarah A. Hiles, Krystelle Godbout, Erin S. Harvey, Guy B. Marks, Mark Hew, Matthew Peters, Philip G. Bardin, Paul N. Reynolds, John W. Upham, Melissa Baraket, Zaheerodin Bhikoo, Jeffrey Bowden, Ben Brockway, Li Ping Chung, Belinda Cochrane, Gloria Foxley, Jeffrey Garrett, Lata Jayaram, Christine Jenkins, Constance Katelaris, Gregory Katsoulotos, Mariko S. Koh, Vicky Kritikos, Marina Lambert, David Langton, Alexis Lara Rivero, Peter G. Middleton, Aldoph Nanguzgambo, Naghmeh Radhakrishna, Helen Reddel, Janet Rimmer, Anne Marie Southcott, Michael Sutherland, Francis Thien, Peter A.B. Wark, Ian A. Yang, Elaine Yap, and Peter G. Gibson

DOI: 10.1111/resp.13389

 

 

Effects of emphysema on physiological and prognostic characteristics of lung function in idiopathic pulmonary fibrosis

Hee‐Young Yoon, Tae Hoon Kim, Joon Beom Seo, Sang Min Lee, Soyeoun Lim, Han Na Lee, Namkug Kim, Minkyu Han, Dong Soon Kim, and Jin Woo Song.

DOI: 10.1111/resp.13387

 

CT scans of a patient with IPF and 7.6% emphysema [LEFT], and a texture-based automated quantitative system classification denoting regional patterns of lung tissue [RIGHT], including normal (green), reticular opacity (cyan), emphysema (red), consolidation (pink) and honeycombing (blue).

 

Predictive factors and prognostic effect of telomere shortening in pulmonary fibrosis

Lurdes Planas‐Cerezales, Elena G. Arias‐Salgado, Ivette Buendia‐Roldán, Ana Montes‐Worboys, Cristina Esquinas López, Vanesa Vicens‐Zygmunt, Patricio Luburich Hernaiz, Roger Llatjós Sanuy, Virginia Leiro‐Fernandez, Eva Balcells Vilarnau, Ernest Sala Llinás, Jordi Dorca Sargatal, Rosario Perona Abellón, Moisés Selman, and Maria Molina‐Molina.

DOI: 10.1111/resp.13423

 

Transplant-free survival time according to the presence or absence of telomere shortening in combination of being younger or older than 60 years of age.

 

Pulmonary arterial hypertension in a multi-ethnic Asian population: Characteristics, survival and mortality predictors from a 14-year follow-up study

Yinghao Lim, Ting‐Ting Low, Siew‐Pang Chan, Ting Wei Teo, Jin‐Hao Justin Jang, Nicole Yip, Ivandito Kuntjoro, Edgar Lik‐Wui Tay, and James Wei‐Luen Yip.

DOI: 10.1111/resp.13392

 

The pulmonary hypertension team at the National University Heart Centre in Singapore; from left to right: Edgar Tay, Ivandito Kuntjoro, Justin Jang, Siew Pang Chan, Ting Ting Low, Geying Li, Ai Huong Then, Ting Wei Teo and Yinghao Lim. Missing from this photo are authors Nicole Yip and James Yip.

 

Understanding the patient’s experience of care in idiopathic pulmonary fibrosis

Kimberley Burnett, Ian Glaspole, and Anne E. Holland

DOI: 10.1111/resp.13414

 

The Alfred Hospital in Melbourne, Australia (Source: Public Affairs, The Alfred)

 

Choosing the right mask for your Asian patient with sleep apnoea: A randomized, crossover trial of CPAP interfaces

Ken Junyang Goh, Rui Ya Soh, Leong Chai Leow, Song Tar Toh, Pei Rong Song, Ying Hao, Ken Cheah Hooi Lee, Gan Liang Tan, and Thun How Ong.

DOI: 10.1111/resp.13396

 

Example of a CPAP therapy mask for patients with OSA

Research Project and Survey Requests

Current Opinions of Severe Asthma Specialists on the Utility of Biomarkers for the Management of Corticosteroid Treatment: A Survey

If you are an Australian clinician involved in the care of patients with severe asthma, we would be very grateful if you could complete a brief questionnaire.

We would ideally like to sample opinions from specialists involved in the care and management of patients with severe asthma to reach consensus. This is the second round of a multi-national Delphi process to reach a consensus and there may be follow-up questions based on the answers we receive from this round (with likely 2-3 rounds in total).

A strategy to optimize corticosteroid use in the severe asthma population using biomarkers is currently being investigated. Professors Peter Wark and Jodie Simpson at the University of Newcastle, Australia are looking at an algorithm to adjust corticosteroid dose using exhaled nitric oxide (FeNO), and peripheral blood eosinophils. This survey is being conducted by them, and will also be part of a Masters by Research by Dr. James Michael Ramsahai. As part of this project, we would like to seek your views on some aspects of biomarker based corticosteroid adjustment in severe asthma.

For more details, please see the attached information statement. Please note that completion of the survey will imply consent to participate, and for the data collected to be used for analysis. You may withdraw at any time.

If you agree to participate, please follow the link to complete the survey

http://selectsurvey.hnehealth.nsw.gov.au/TakeSurvey.aspx?SurveyID=78M2nn61

*for issues with the survey link, please try copying and pasting into your browser and/or using Firefox browser. Feel free to contact the investigators with any questions*

Thank you,

Peter Wark
Jodie Simpson
J. Michael Ramsahai
 JamesMichael.Ramsahai@uon.edu.au

 

Management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics

Dear TSANZ Member,

You are invited to participate in a survey that is being conducted as part of a research study. The following survey asks a series of questions about your current practice, specifically with regards to the management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics. Insights gained will be considered for future presentation and publication. The estimated time to complete the survey is 10 minutes. Partial responses will not be saved if you exit out the survey early. Your participation is voluntary and anonymous. Responses will be kept confidential. Your contribution is greatly appreciated.

The survey can be completed here: https://hms.az1.qualtrics.com/jfe/form/SV_8ddQsXRFwaqAtPD

If you have any questions about the survey, please contact the study team at: vholden@som.umaryland.edu

We thank you in advance for your participation.

Sincerely,

Van Holden, MD
Mihir Parikh, MD
Alex Chee, MD
Adnan Majid, MD

Division of Thoracic Surgery & Interventional Pulmonology
Beth Israel Deaconess Medical Center
Harvard Medical School

The attached survey has been approved by the Beth Israel Deaconess Institutional Review Board – The IRB Protocol # is 2018P000052.

 

Centre for Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT)

ANZ health professionals who care for people with lung cancer are invited to take part in a survey about the clinical importance and management of cough.

Cough in lung cancer – a health professional survey

The survey link is: https://www.surveymonkey.com/r/cough_in_lung_cancer

Survey results will be used to establish the need and direction for development of further pharmacological and non-pharmacological management strategies for cough in lung cancer.

We are interested in the views of health professionals from the full range of disciplines, specialties and settings involved in caring for people with lung cancer, regardless of their level of experience in managing cough.

Participation in the survey is voluntary and anonymous, and will take approximately 10-15 minutes.

This project is being conducted by a team of researchers from the University of Technology Sydney (UTS) in collaboration with colleagues at the Hong Kong Polytechnic University (HKPU).

For more information, please contact Dr Tim Luckett via tim.luckett@uts.edu.au or 02 9514 4861.

 
 

.

VOLUME 4.02 APRIL 2019

VOLUME 3.09 DECEMBER 2018

Research Roundup:

December 2018

.
 

Welcome Message

As the year draws to a close and many of us are wrapping up for the summer break we have a few short messages for you.

Firstly, we have two awards open which we would like to draw your attention to:

Secondly, late-breaking abstracts are open, so if you have any new work to share with your colleagues, please consider submitting to TSANZSRS19!

Lastly, we wish you all a safe and relaxing break over the festive season. For those who will remain at work, we hope all goes smoothly for you! Enjoy the December edition of your research roundup and please check out the surveys below.

Profs Phil Hansbro & Sandra Hodge

Co-Chairs, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ / LFA / CSL Behring Research Award for Alpha-1 anti-trypsin deficiency – closes 14 Feb 19

TSANZ Indigenous Respiratory Nursing Award – closes 31 Jan 19

Cystic Fibrosis Australia Awards

Cystic Fibrosis Innovation Grant – closes 28 Jan 2019

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

Respirology – Editor’s Choice

Respirology Issue 23.12 (December 2018)

Inflammation-dependent and independent airway remodelling in asthma

John G. Elliot, Peter B. Noble, Thais Mauad, Tony R. Bai, Michael J. Abramson, Karen O. McKay, Francis H.Y. Green, Alan L. James

DOI: 10.1111/resp.13360

 

1000-fold magnification of the airway smooth muscle layer with a counting grid overlay for planimetry assessment of the airway smooth muscle area.

Obstructive sleep apnoea independently predicts lipid levels: Data from the European Sleep Apnea Database

Canan Gündüz, Ozen K. Basoglu, Jan Hedner, Ding Zou, Maria R. Bonsignore, Holger Hein, Richard Staats, Athanasia Pataka, Ferran Barbe, Pavel Sliwinski, Brian D. Kent, Jean Lois Pepin, ​​​​​​​Ludger Grote, on behalf of the European Sleep Apnea Database Collaborators.

DOI: 10.1111/resp.13372

 

ESADA researchers and collaborators from left to right: Holger Hein, Sven Svedmyr, Ding Zou, Canan Gündüz, Ludger Grote.

Research Project and Survey Requests

Current Opinions of Severe Asthma Specialists on the Utility of Biomarkers for the Management of Corticosteroid Treatment: A Survey

If you are an Australian clinician involved in the care of patients with severe asthma, we would be very grateful if you could complete a brief questionnaire.

We would ideally like to sample opinions from specialists involved in the care and management of patients with severe asthma to reach consensus. This is the second round of a multi-national Delphi process to reach a consensus and there may be follow-up questions based on the answers we receive from this round (with likely 2-3 rounds in total).

A strategy to optimize corticosteroid use in the severe asthma population using biomarkers is currently being investigated. Professors Peter Wark and Jodie Simpson at the University of Newcastle, Australia are looking at an algorithm to adjust corticosteroid dose using exhaled nitric oxide (FeNO), and peripheral blood eosinophils. This survey is being conducted by them, and will also be part of a Masters by Research by Dr. James Michael Ramsahai. As part of this project, we would like to seek your views on some aspects of biomarker based corticosteroid adjustment in severe asthma.

For more details, please see the attached information statement. Please note that completion of the survey will imply consent to participate, and for the data collected to be used for analysis. You may withdraw at any time.

If you agree to participate, please follow the link to complete the survey

http://selectsurvey.hnehealth.nsw.gov.au/TakeSurvey.aspx?SurveyID=78M2nn61

*for issues with the survey link, please try copying and pasting into your browser and/or using Firefox browser. Feel free to contact the investigators with any questions*

Thank you,

Peter Wark
Jodie Simpson
J. Michael Ramsahai
 JamesMichael.Ramsahai@uon.edu.au

 

Management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics

Dear TSANZ Member,

You are invited to participate in a survey that is being conducted as part of a research study. The following survey asks a series of questions about your current practice, specifically with regards to the management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics. Insights gained will be considered for future presentation and publication. The estimated time to complete the survey is 10 minutes. Partial responses will not be saved if you exit out the survey early. Your participation is voluntary and anonymous. Responses will be kept confidential. Your contribution is greatly appreciated.

The survey can be completed here: https://hms.az1.qualtrics.com/jfe/form/SV_8ddQsXRFwaqAtPD 

If you have any questions about the survey, please contact the study team at: vholden@som.umaryland.edu

We thank you in advance for your participation.

Sincerely,

Van Holden, MD
Mihir Parikh, MD
Alex Chee, MD
Adnan Majid, MD

Division of Thoracic Surgery & Interventional Pulmonology
Beth Israel Deaconess Medical Center
Harvard Medical School

The attached survey has been approved by the Beth Israel Deaconess Institutional Review Board – The IRB Protocol # is 2018P000052.

 

Centre for Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT)

ANZ health professionals who care for people with lung cancer are invited to take part in a survey about the clinical importance and management of cough.

Cough in lung cancer – a health professional survey

The survey link is: https://www.surveymonkey.com/r/cough_in_lung_cancer

Survey results will be used to establish the need and direction for development of further pharmacological and non-pharmacological management strategies for cough in lung cancer.

We are interested in the views of health professionals from the full range of disciplines, specialties and settings involved in caring for people with lung cancer, regardless of their level of experience in managing cough.

Participation in the survey is voluntary and anonymous, and will take approximately 10-15 minutes.

This project is being conducted by a team of researchers from the University of Technology Sydney (UTS) in collaboration with colleagues at the Hong Kong Polytechnic University (HKPU).

For more information, please contact Dr Tim Luckett via tim.luckett@uts.edu.au or 02 9514 4861.

 
 

.

VOLUME 4.02 APRIL 2019

VOLUME 3.08 NOVEMBER 2018

Research Roundup:

November 2018

.
 

Welcome Message

We are now well into the penultimate month of the year, and for the Thoracic Society this sparks the beginning of the busy lead up to our national conference. The Research Subcommittee is in full swing reviewing award applications, the SIG convenors are busy reviewing abstract submissions, and our conference organisers are ensuring the sessions are programmed smoothly to present your research in the best way possible. For 2019 we are expecting another large conference, having received approximately 400 submissions. Details are gradually being added to the TSANZSRS site and the early program is now visible. Early bird registration is available until the 18th of January, 2019.

Thanks to the many who recently submitted award applications. We would like to highlight that a number of awards are still open and some have been extended – please look below or on our website to find out more information.

Finally, here is an open invitation for TSANZ members who would like to share their Research Story with us. We have been working with The limbic for nearly three years now to bring you the latest research media in our research roundup. Part of this roundup occasionally features TSANZ members and their “holy grail”. This section will also feature on the limbic’s respiratory news website and be visible to other subscribers. If you would like to share your holy grail, please tell us a little bit about yourself here.

Enjoy the November edition of your research roundup and please check out the surveys below!

Profs Phil Hansbro & Sandra Hodge

Co-Chairs, Research Sub-Committee

Open Awards

Thoracic Society Awards

Research and Career Development Awards

Maurice Blackburn ASM Travel Award extended –  closes 3 Dec 18

Boehringer Ingelheim COPD Research Award – closes 3 Dec 18

TSANZ Indigenous Respiratory Nursing Award – reopened – closes 3 Dec 18

Joint Awards

TSANZ / LFA / CSL Behring Research Award for Alpha-1 anti-trypsin deficiency extended –  closes 3 Dec 18

Cystic Fibrosis Australia Awards

Cystic Fibrosis Innovation Grant – closes 28 Jan 2019

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

TSANZ Webinar Series

“What’s in a cough? Implications for the care of people with flu and MROs” with Professor Scott Bell

Event Date: Tuesday, 27th November 2018

Time: 2pm – 3pm AEDT

Duration: 45 minutes

The CF-Air Research Program has provided novel data regarding the prevalence of shared strain infection in CF, potential acquisition pathways including from the natural environment and via direct person-to-person spread of bacteria. This was possible due to the establishment of a multi-disciplinary research team to support studies of the mechanism of cross-infection using CF as a model. Our current work focusses on other CF pathogens and origins and acquisition pathways including Mycobacterium and the potential spread of infection amongst patients with non-CF lung diseases. We have evaluated cough aerosols are highly innovative as no such equipment has been replicated to date, providing in vivo cough studies, safely delivered to patients with respiratory infections.

Only limited places available! Don’t miss out!

The presenter: Professor Scott Bell

Professor Scott Bell is Executive Director – Research, MNHHS and a Senior Physician of the Adult Cystic Fibrosis Centre at TPCH (>320 patients) where he has worked since 1996. He is currently the Editor-in-Chief of the Journal of Cystic Fibrosis. He leads the Lung Bacteria Laboratory at QIMR Berghofer Medical Research Institute in Brisbane. Scott has over 200 peer reviewed publications and has received grant support in excess of $12 million over the past 10 years. His research interests include the CF microbiology, acquisition pathways for human infection and has a long history of supporting multi-disciplinary research. He has been PI on numerous pivotal CFTR modulator trials and is global PI on a novel approach to combination therapies for CFTR correction.

CLICK HERE to register! 

________________________________________________________________________________

Missed out on a webinar? 

The videos from our previous webinars are now available for on-demand viewing. For more information, please CLICK HERE!

Respirology – Editor’s Choice

Respirology Issue 23.11 (November 2018)

Predictive value of eosinophils and neutrophils on clinical effects of ICS in COPD

Floor J. Hartjes, Judith M. Vonk, Alen Faiz, Pieter S. Hiemstra, Thérèse S. Lapperre, Huib A.M. Kerstjens, Dirkje S. Postma, Maarten van den Berge and the Groningen and Leiden Universities Corticosteroids in Obstructive Lung Disease (GLUCOLD) Study Group

DOI: 10.1111/resp.13312

 

               Groningen Research Institute for Asthma and COPD (GRIAC), The Netherlands.

Multidimensional improvement in connective tissue disease associated interstitial lung disease: Two courses of pulse dose methylprednisolone followed by low-dose prednisone and tacrolimus

Yasuhiko Yamano, Hiroyuki Taniguchi, Yasuhiro Kondoh, Masahiko Ando, Kensuke Kataoka, ​​​​​​​Taiki Furukawa, Takeshi Johkoh, Junya Fukuoka, Koji Sakamoto, Yoshinori Hasegawa

DOI: 10.1111/resp.13365

 

Research team at Department of Respiratory Medicine and Allergy at Tosei General Hospital in Seto, Japan.

Research Project and Survey Requests

Current Opinions of Severe Asthma Specialists on the Utility of Biomarkers for the Management of Corticosteroid Treatment: A Survey

If you are an Australian clinician involved in the care of patients with severe asthma, we would be very grateful if you could complete a brief questionnaire.

We would ideally like to sample opinions from specialists involved in the care and management of patients with severe asthma to reach concensus. This is the second round of a multi-national Delphi process to reach a consensus and there may be follow-up questions based on the answers we receive from this round (with likely 2-3 rounds in total).

A strategy to optimize corticosteroid use in the severe asthma population using biomarkers is currently being investigated. Professors Peter Wark and Jodie Simpson at the University of Newcastle, Australia are looking at an algorithm to adjust corticosteroid dose using exhaled nitric oxide (FeNO), and peripheral blood eosinophils. This survey is being conducted by them, and will also be part of a Masters by Research by Dr. James Michael Ramsahai. As part of this project, we would like to seek your views on some aspects of biomarker based corticosteroid adjustment in severe asthma.

For more details, please see the attached information statement. Please note that completion of the survey will imply consent to participate, and for the data collected to be used for analysis. You may withdraw at any time.

If you agree to participate, please follow the link to complete the survey

http://selectsurvey.hnehealth.nsw.gov.au/TakeSurvey.aspx?SurveyID=78M2nn61

*for issues with the survey link, please try copying and pasting into your browser and/or using Firefox browser. Feel free to contact the investigators with any questions*

Thank you,

Peter Wark
Jodie Simpson
J. Michael Ramsahai
 JamesMichael.Ramsahai@uon.edu.au

 

Implementation of Severe Asthma Management

About the Survey:

On behalf of the NHMRC Centre of Excellence in Severe Asthma (www.severeasthma.org.au), we request your assistance in completing a short survey regarding the implementation of management strategies for severe asthma. We are seeking feedback from multidisciplinary healthcare professionals in Australia.

The survey is available at the following link: https://www.surveymonkey.com/r/SevereAsthmaCRE

The results from this survey will inform expert forum discussions, ongoing research and development of resources to support translation and implementation of new findings into clinical practice. Our goal is to use this information to develop improved standards of care through the NHMRC Centre of Excellence in Severe Asthma.

This survey consists of 15 questions and we anticipate it will take less than 10 minutes to complete.

If respondents can submit their responses by Friday 02 November 2018 it will be greatly appreciated.

Thank you and kind regards,

Profs. Peter Gibson, Vanessa McDonald and John Upham, on behalf of the Centre of Excellence in Severe Asthma

This survey has been approved by the HNELHD HREC under authorisation number AU201809-09. All responses are completely anonymous and will be kept strictly confidential. If you experience any issues or have any questions, please contact: severeasthma@newcastle.edu.au

 

Management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics

Dear TSANZ Member,

You are invited to participate in a survey that is being conducted as part of a research study. The following survey asks a series of questions about your current practice, specifically with regards to the management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics. Insights gained will be considered for future presentation and publication. The estimated time to complete the survey is 10 minutes. Partial responses will not be saved if you exit out the survey early. Your participation is voluntary and anonymous. Responses will be kept confidential. Your contribution is greatly appreciated.

The survey can be completed here: https://hms.az1.qualtrics.com/jfe/form/SV_8ddQsXRFwaqAtPD 

If you have any questions about the survey, please contact the study team at: vholden@som.umaryland.edu

We thank you in advance for your participation.

Sincerely,

Van Holden, MD
Mihir Parikh, MD
Alex Chee, MD
Adnan Majid, MD

Division of Thoracic Surgery & Interventional Pulmonology
Beth Israel Deaconess Medical Center
Harvard Medical School

The attached survey has been approved by the Beth Israel Deaconess Institutional Review Board – The IRB Protocol # is 2018P000052.

 

Centre for Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT)

ANZ health professionals who care for people with lung cancer are invited to take part in a survey about the clinical importance and management of cough.

Cough in lung cancer – a health professional survey

The survey link is: https://www.surveymonkey.com/r/cough_in_lung_cancer

Survey results will be used to establish the need and direction for development of further pharmacological and non-pharmacological management strategies for cough in lung cancer.

We are interested in the views of health professionals from the full range of disciplines, specialties and settings involved in caring for people with lung cancer, regardless of their level of experience in managing cough.

Participation in the survey is voluntary and anonymous, and will take approximately 10-15 minutes.

This project is being conducted by a team of researchers from the University of Technology Sydney (UTS) in collaboration with colleagues at the Hong Kong Polytechnic University (HKPU).

For more information, please contact Dr Tim Luckett via tim.luckett@uts.edu.au or 02 9514 4861.

 
 
 

.

VOLUME 4.02 APRIL 2019

VOLUME 3.07 OCTOBER 2018

Research Roundup:

October 2018

.
 

Welcome Message

Welcome to October – a busy month for awards as the first wave of awards close and the second wave of awards open. We are pleased to announce that the Boehringer Ingelheim COPD Research Award is now open, and the Boehringer Ingelheim Australia COPD Travel Award and Boehringer Ingelheim New Zealand COPD Travel Award have been added to the TSANZSRS2019 abstract submission portal.

Don’t forget that Abstract-linked awards are closing soon! (this Friday!) Apply now for some of the many abstract-linked awards and, for early career researchers, take the opportunity to present your work to our full membership by entering the Ann Woolcock New Investigator competition.

The full list of awards can be found in the Open Awards section in this newsletter and on the TSANZ Awards web page.

Lastly, please support the research of TSANZ members and supporters by contributing to the surveys at the end of this newsletter.

Enjoy the October edition of your research roundup.

Profs Phil Hansbro & Sandra Hodge

Co-Chairs, Research Sub-Committee

Open Awards

Thoracic Society Awards

Abstract-linked awards

To apply for an abstract-linked award, you must complete the application coversheet using the upload functionality in the online abstract submission portal

Ann Woolcock New Investigator Award

Boehringer Ingelheim COPD Travel Award (AU)

Boehringer Ingelheim COPD Travel Award (NZ)

Janet Elder International Travel Award

Japanese Respiratory Society (JRS) Early Career Development

TSANZ Travel Grants to 2019 ASM

For more information visit http://www.tsanzsrs2019.com/abstracts/tsanz-awards-criteria/

Abstracts close 12 October 2018 6pm AEST

Research and Career Development Awards

TSANZ Peter Phelan Research Award – closes 31 Oct 18

TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health – closes 31 Oct 18

TSANZ Indigenous Respiratory Nursing Award – closes 31 Oct 18

Maurice Blackburn Grant-in-Aid for Occupational Lung Disease – closes 18 Nov 18

Maurice Blackburn ASM Travel Award – closes 18 Nov 18

Boehringer Ingelheim COPD Research Award – closes 3 Dec 18

Joint Awards

TSANZ / LFA / CSL Behring Research Award for Alpha-1 anti-trypsin deficiency – closes 31 Oct 18

TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship – closes 31 Oct 18

Cystic Fibrosis Australia Awards

Cystic Fibrosis Innovation Grant – closes 28 Jan 2019

Lung Foundation Australia Awards

The Lung Foundation Australia David Wilson PhD Scholarship in Idiopathic Pulmonary Fibrosis 2019 – closes 10 Oct 18

Lung Foundation Australia/ Cochrane Airways Australia Scholarship 2019 – closes 2 Nov 18

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

Cystic Fibrosis Innovation Grant

Cystic Fibrosis Australia (CFA) is pleased to announce the 2019 Innovation Grant for post-doctoral researchers, currently working in cystic fibrosis (CF) research. This grant is awarded annually to one applicant for one year.

The Innovation Grant will allow a CF researcher to explore novel concepts at the initial feasibility stage.  Innovative applications relating to any aspect in the field of CF are encouraged, even those lacking pilot data.  The grant aims to allow the researcher to generate sufficient data within the one-year grant period to be in a position to apply for additional support from an appropriate funding body to continue the research.

The Innovation grant will be offered to post-doctoral researchers currently working in or proposing to work in CF research.  The researcher will have completed a research higher degree in CF or a related area within the last ten years.

The recipient of the Innovation Grant is required to provide progress reports on their research to CFA every six months.  In addition, and where appropriate, the recipient will be asked to make a presentation at a CFA conference (held every two years) in Australia.

The maximum amount awarded under the Innovation Grant will be $80,000.  The actual amount provided will be subject to approval of the applicant’s budget.

Applications can be made through the website of The Thoracic Society of Australia & New Zealand (TSANZ) and must be received by TSANZ by late January 2019.

Apply Here

TSANZ Webinar Series

Thursday 11th October 2018, 1pm AEDT | 3pm NZDT

Research Techniques to Study Respiratory Diseases – Prof Phil Hansbro

The webinar will be discussing a range of techniques that are valuable for studying disease, identifying new therapeutic targets and testing novel treatments. 

Professor Phil Hansbro Biography:

Professor Hansbro is a group leader and holds a personal chair in immunology and microbiology at the Hunter Medical Research Institute and University of Newcastle, Australia and is Associate Director of the Priority Research Centre for Asthma and Respiratory Diseases there. He is also an NHMRC Principal Research Fellow. He has established internationally recognised research programs in infections, COPD, asthma and recently lung cancer. His group has developed several novel mouse models of the important diseases (COPD, severe, steroid-insensitive asthma, early life infection & lung cancer). He has interrogated them (immune, histological, pathological, lung function & molecular analysis) to substantially further our understanding of pathogenesis and to develop novel therapies. He performs complimentary collaborative clinical and multi-disciplinary studies and collaborates widely. He publishes extensively in influential journals and he is regularly invited to present internationally including as plenary and to chair sessions. He has a substantial funding record of obtaining nationally competitive grants that support his group. He undertakes substantial mentoring and supervision activities of junior researchers, regularly sits on grant review panels and is on the editorial board of 4 journals. He is an active advocate for respiratory research in lobby groups and is regularly in the press promoting research and funding.

CLICK HERE to register! 

________________________________________________________________________________

Missed out on a webinar? 

The videos from our previous webinars with Professor Allan Glanville and Sally Powell are now available for on-demand viewing. For more information, please CLICK HERE!

Thoracic Society Medals and FThorSoc

Each year the TSANZ invites members to nominate their peers to be considered for a number of prestigious awards, namely: Research Medal, Society Medal and 50th Anniversary Medal for Education & Training. Nominations for these awards are now invited from members of all backgrounds and professions. Recipients of these awards will be presented with their medals at the TSANZSRS 2019 Gala Dinner and Awards Evening.  

Members are also encouraged to consider applying to become a Fellow of TSANZ. Applications for Fellow status are reviewed by the Professional Standards Subcommittee and reviewed and endorsed by the Board. Fellow status is available to members from all professions who demonstrate an exceptional contribution to the field of respiratory health in Australia or New Zealand. If the Fellow status is approved, the member will be able to use the post nominal FThorSoc and will be able to continue to do so whilst a financial member of TSANZ. Recipients of the post nominal FThorSoc will be announced at the AGM 2019.

The Research Medal, Society Medal, 50th Anniversary Medal and Fellows of TSANZ are distinctive awards – a testament of the recipients’ exceptional contributions in the field of respiratory health in Australia or New Zealand.

Read below for more details & how to apply/nominate your peers. Closing date: Friday 2nd November 2018

TSANZ Fellowship 

DOWNLOAD APPLICATION FORM

For more information please visit: https://www.thoracic.org.au/about-us/fellow-of-thoracic-society-australia-new-zealand

Background:

The TSANZ Board makes an annual call for nominations for members to be awarded Fellow status. The call is made to members from all professions who demonstrate exceptional contribution to the field of respiratory health in Australia or New Zealand. If the Fellow status is approved, the member will be able to use the post nominal FThorSoc and will be able to continue to do so whilst a financial member of TSANZ.

The main aims of the Fellow status are:

  1. To recognise expertise and experience in respiratory medicine and/or research and/or respiratory health service provision.
  2. To acknowledge a major contribution and commitment to advancing respiratory health in Australia and/ or New Zealand.

Requirements for Awarding of FThorSoc:

TSANZ members may apply to become a Fellow of the Thoracic Society of Australia and New Zealand (FThorSoc) if they demonstrate exceptional contribution to 5 of the 7 criteria listed below. For the remaining 2 criteria, the applicant must demonstrate a proven track record.

The criteria are:

  1. A continuous financial member of TSANZ for five consecutive years in Australia and/or New Zealand as well as a minimum of ten years post-specialist qualification
  2. Contribution to advocacy and/or policy development
  3. Service within the community
  4. Distinguished leadership
  5. Contribution to research
  6. Contribution to teaching or training
  7. International recognition in his or her discipline

List of Fellows of The Thoracic Society Australia and New Zealand:

The following individuals have been nominated by their peers, recommended to the Board by the Professional Standards Sub-Committee and formally recognised by the Board for their exceptional contributions to respiratory health in Australia and New Zealand.

FTHORSOC 2013

FTHORSOC 2014

FTHORSOC 2015

FTHORSOC 2016

FTHORSOC 2017 

FTHORSOC 2018 

___________________________________________________________

Awards By Nomination

The Research Medal, Society Medal and 50th Anniversary Medal are awards for distinguished service. Nominations for each of these awards are invited as outlined below. 

 

The Research Medal 

About 

The Research Medal may be awarded each year in recognition of outstanding contributions to the advancement of knowledge in respiratory medicine or science carried out primarily in Australia or New Zealand. The award recognises an individual who has demonstrated sustained excellence in their field of research.

HOW TO NOMINATE

Candidates

The Research Medal is open to all financial members of TSANZ including Associate members. Candidates for this medal are put forward by nomination only.

Recipient

The successful candidate will be presented with an engraved Research Medal at the TSANZ Annual Scientific Meeting. An official notification letter from the President of TSANZ will be sent to the successful candidate.  

The Society Medal 

About

The Society Medal was conceived as an acknowledgement of excellence in fields other than research, i.e. for the advancement of the practice of thoracic medicine in its widest sense by outstanding teaching or advocacy. The inaugural Society Medal was presented at the annual dinner in Canberra in 1992 to Dr Maurice Joseph, who ably embodied the qualities envisaged by this senior prestigious award.

HOW TO NOMINATE

Candidates

The Society Medal is open to all financial members of TSANZ including Associate members. Candidates for this medal are put forward by nomination only.

Recipient

The successful candidate will be presented with an engraved Society Medal at the TSANZ Annual Scientific Meeting. An official notification letter from the President of TSANZ will be sent to the successful candidate.  

The 50th Anniversary Medal for Education and Training 

About

The 50th Anniversary Medal is an award introduced in 2011 to mark the Society’s 50th Anniversary. The 50th Anniversary Medal may be awarded each year in recognition of outstanding contributions to respiratory education and training in New Zealand or Australia. The award recognises an individual who has demonstrated sustained excellence in education and training. This might take the form of formal and informal teaching within a university, hospital or other health care setting; curriculum development at an undergraduate or postgraduate level; using research to enhance the efficacy of educational activities; career mentoring of junior members of the Society; integration of teaching into clinical practice; or advocacy on behalf of medical education as applied to respiratory medicine.

HOW TO NOMINATE

Candidates

The 50th Anniversary Medal is open to all financial members of TSANZ including Associate members. Candidates for this medal are put forward by nomination only.

Recipient

The successful candidate will be presented with an engraved 50th Anniversary Medal at the TSANZ Annual Scientific Meeting. An official notification letter from the President of TSANZ will be sent to the successful candidate. 

Clinical Trials Workshop

The Centre of Excellence is pleased to be hosting a Clinical Trials Workshop on 24 October 2018 from 1 – 4PM at the Hunter Medical Research Institute, Caves Theatre. We believe this session will be of broad interest and would appreciate your support in distributing this invitation as broadly as possible.

We are pleased to confirm 4 experts in the field presenting on:

1:00 – 1:40: Clinical Trials Funding (Prof. Bruce Neal, The George Institute)

1:40 – 2:50: Integrating Public Involvement in Research and Clinical Trials (Prof. William Tarnow-Mordi, NHMRC CTC & Melinda Cruz, Miracle Babies Foundation)

3:20 – 4:00: Designing Implementation Trials (Prof. John Wiggers, University of Newcastle)

An event flyer can be downloaded at: https://www.severeasthma.org.au/wp-content/uploads/2018/09/24Oct2018-Clinical-Trials-Workshop.pdf

Lunch will be served before the event and refreshments during an intermission. Please RSVP your interest for catering purposes to severeasthma@newcastle.edu.au

Respirology – Editor’s Choice

Respirology Issue 23.10 (October 2018)

Annual Southeast Asia haze increases respiratory admissions: A 2-year large single institution experience.

Chew R. Ming, Andrea Ban Yu‐Lin, Mohammad F. Abdul Hamid, Mohd T. Latif, Nurashikin Mohammad, Tidi Hassan

DOI: 10.1111/resp.13325

 

Satellite image of the 2015 SE-Asia haze

 

GeneXpert MTB/RIF for rapid diagnosis and rifampin resistance detection of endobronchial tuberculosis

Qin Zhang, Qing Zhang, Bing‐qi Sun, Chang Liu, An‐na Su, Xiao‐han Wang, Na Liu, Juan Zhang, Jian Kang, Gang Hou

DOI: 10.1111/resp.13316

 

The research team from Shenyang, China, with the GeneXpert MTB/RIF system. From left to right: Xiao-han Wang, Chang Liu, Qin Zhang, Bing-qi Sun (front row); Qing Zhang, Gang Hou, An-na Su, Na Liu (Back row).

Research Project and Survey Requests

Implementation of Severe Asthma Management

About the Survey:

On behalf of the NHMRC Centre of Excellence in Severe Asthma (www.severeasthma.org.au), we request your assistance in completing a short survey regarding the implementation of management strategies for severe asthma. We are seeking feedback from multidisciplinary healthcare professionals in Australia.

The survey is available at the following link: https://www.surveymonkey.com/r/SevereAsthmaCRE

The results from this survey will inform expert forum discussions, ongoing research and development of resources to support translation and implementation of new findings into clinical practice. Our goal is to use this information to develop improved standards of care through the NHMRC Centre of Excellence in Severe Asthma.

This survey consists of 15 questions and we anticipate it will take less than 10 minutes to complete.

If respondents can submit their responses by Friday 02 November 2018 it will be greatly appreciated.

Thank you and kind regards,

Profs. Peter Gibson, Vanessa McDonald and John Upham, on behalf of the Centre of Excellence in Severe Asthma

This survey has been approved by the HNELHD HREC under authorisation number AU201809-09. All responses are completely anonymous and will be kept strictly confidential. If you experience any issues or have any questions, please contact: severeasthma@newcastle.edu.au

 

Management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics

Dear TSANZ Member,

You are invited to participate in a survey that is being conducted as part of a research study. The following survey asks a series of questions about your current practice, specifically with regards to the management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics. Insights gained will be considered for future presentation and publication. The estimated time to complete the survey is 10 minutes. Partial responses will not be saved if you exit out the survey early. Your participation is voluntary and anonymous. Responses will be kept confidential. Your contribution is greatly appreciated.

The survey can be completed here: https://hms.az1.qualtrics.com/jfe/form/SV_8ddQsXRFwaqAtPD 

If you have any questions about the survey, please contact the study team at: vholden@som.umaryland.edu

We thank you in advance for your participation.

Sincerely,

Van Holden, MD
Mihir Parikh, MD
Alex Chee, MD
Adnan Majid, MD

Division of Thoracic Surgery & Interventional Pulmonology
Beth Israel Deaconess Medical Center
Harvard Medical School

The attached survey has been approved by the Beth Israel Deaconess Institutional Review Board – The IRB Protocol # is 2018P000052.

 

Centre for Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT)

ANZ health professionals who care for people with lung cancer are invited to take part in a survey about the clinical importance and management of cough.

Cough in lung cancer – a health professional survey

The survey link is: https://www.surveymonkey.com/r/cough_in_lung_cancer

Survey results will be used to establish the need and direction for development of further pharmacological and non-pharmacological management strategies for cough in lung cancer.

We are interested in the views of health professionals from the full range of disciplines, specialties and settings involved in caring for people with lung cancer, regardless of their level of experience in managing cough.

Participation in the survey is voluntary and anonymous, and will take approximately 10-15 minutes.

This project is being conducted by a team of researchers from the University of Technology Sydney (UTS) in collaboration with colleagues at the Hong Kong Polytechnic University (HKPU).

For more information, please contact Dr Tim Luckett via tim.luckett@uts.edu.au or 02 9514 4861.

 
 
 
 

.

VOLUME 4.02 APRIL 2019

VOLUME 3.06 SEPTEMBER 2018

Research Roundup:

September 2018

.
 

Welcome Message

Like many of our members, we have recently returned from the European Respiratory Society Congress where an overwhelming amount of scientific and clinical advances, discussions and debates were had over five days. The abstracts for most sessions can be found here and the limbic have provided us with some articles below highlighting key messages.

Our members had a very successful meeting and we applaud the work by the numerous TSANZ members who were recognised by the ERS for their research, including;

  • Peter Gibson – ERS Gold Medal in Asthma
  • Jodie Simpson – ERS Romain Pauwels Research Award
  • Gary Anderson – ERS Presidential Award
  • Sally Yunsun Kim – Co-funded Long-Term Research Fellowship 2018.
  • Pawan Sharma – Short-term Research Fellowship – April 2018 round
  • Louisa Organ – ERS Fellowship Recipient 2017-2019
  • Louisa Owens – ERS Grant for Best Abstract in Paediatric Respiratory Physiology
  • David Currow – ERS Grant for Best Abstract in Rehabilitation and Chronic Care
  • Deborah Reynolds-Sandford – ERS/ELS Travel Grant for Best Abstract in Patient-Centred Research

Looking ahead, abstracts to the TSANZSRS19 are closing soon, on the 12th of October. This ASM is themed Respiratory Infection and you will begin to see some exciting plenaries, workshops and symposiums online as the program is populated.

We are pleased to announce that the Maurice Blackburn Grant-in-Aid for Occupational Lung Disease and the Maurice Blackburn ASM Travel Award for allied health and nursing are now open. We would also like to remind you that two LFA awards are still open for submissions, including the LFA Cochrane Airways Australia Scholarship 2019 and the LFA David Wilson PhD Scholarship in Idiopathic Pulmonary Fibrosis 2019

The full list of awards and more information on these can be found in the Open Awards section of this newsletter and on the TSANZ Awards Submissions Portal.

Enjoy the September edition of your research roundup.

Profs Phil Hansbro & Sandra Hodge

Co-Chairs, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ Peter Phelan Research Award – closes 31 Oct 18

TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health – closes 31 Oct 18

TSANZ Indigenous Respiratory Nursing Award – closes 31 Oct 18

Maurice Blackburn Grant-in-Aid for Occupational Lung Disease – closes 18 Nov 18

Maurice Blackburn ASM Travel Award – closes 18 Nov 18

Joint Awards

TSANZ / LFA / CSL Behring Research Award for Alpha-1 anti-trypsin deficiency – closes 31 Oct 18

TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship – closes 31 Oct 18

Lung Foundation Australia Awards

The Lung Foundation Australia David Wilson PhD Scholarship in Idiopathic Pulmonary Fibrosis 2019 – closes 10 Oct 18

Lung Foundation Australia/ Cochrane Airways Australia Scholarship 2019 – closes 2 Nov 18

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

The Next TSANZ Webinar!

Thursday 11th October 2018

1pm AEDT | 2pm NZDT

Research Techniques to Study Respiratory Diseases – Prof Phil Hansbro

The webinar will be discussing a range of techniques that are valuable for studying disease, identifying new therapeutic targets and testing novel treatments. 

Professor Phil Hansbro Biography:

Professor Hansbro is a group leader and holds a personal chair in immunology and microbiology at the Hunter Medical Research Institute and University of Newcastle, Australia and is Associate Director of the Priority Research Centre for Asthma and Respiratory Diseases there. He is also an NHMRC Principal Research Fellow. He has established internationally recognised research programs in infections, COPD, asthma and recently lung cancer. His group has developed several novel mouse models of the important diseases (COPD, severe, steroid-insensitive asthma, early life infection & lung cancer). He has interrogated them (immune, histological, pathological, lung function & molecular analysis) to substantially further our understanding of pathogenesis and to develop novel therapies. He performs complimentary collaborative clinical and multi-disciplinary studies and collaborates widely. He publishes extensively in influential journals and he is regularly invited to present internationally including as plenary and to chair sessions. He has a substantial funding record of obtaining nationally competitive grants that support his group. He undertakes substantial mentoring and supervision activities of junior researchers, regularly sits on grant review panels and is on the editorial board of 4 journals. He is an active advocate for respiratory research in lobby groups and is regularly in the press promoting research and funding.

CLICK HERE to register! 

________________________________________________________________________________

Missed out on a webinar? 

The videos from our previous webinars with Professor Allan Glanville and Sally Powell are now available for on-demand viewing. For more information, please CLICK HERE!

________________________________________________________________________________

Respirology – Editor’s Choice

Respirology Issue 23.9 (September 2018)

Increased risk of acute coronary syndrome in patients with bronchiectasis: A population-based cohort study

Chin‐Tun Hung, Shu‐Fen Li, Wei‐Sheng Chung

DOI: 10.1111/resp.13298

 

Research team from the Taichung Hospital and Central Taiwan University of Science and Technology in Taiwan. From left to right: Drs Chin-Tun Hung, Shu-Fen Li and Wei-Sheng Chung

 

Cost-effectiveness of endobronchial valve treatment in patients with severe emphysema compared to standard medical care

Jorine E. Hartman, Karin Klooster, Henk Groen, Nick H.T. ten Hacken, Dirk‐Jan Slebos

DOI: 10.1111/resp.13295

 

Endobronchial valve (EBV), with permission from PulmonX

Pulmonary Fibrosis Awareness month

It is Pulmonary Fibrosis Awareness month and Respirology have a number of articles available as a Topic in Focus. The collection includes a TSANZ position statement and these Articles will be freely available in the awareness month of September.

 

 

Research Project and Survey Requests

Implementation of Severe Asthma Management

About the Survey:

On behalf of the NHMRC Centre of Excellence in Severe Asthma (www.severeasthma.org.au), we request your assistance in completing a short survey regarding the implementation of management strategies for severe asthma. We are seeking feedback from multidisciplinary healthcare professionals in Australia.

The survey is available at the following link: https://www.surveymonkey.com/r/SevereAsthmaCRE

The results from this survey will inform expert forum discussions, ongoing research and development of resources to support translation and implementation of new findings into clinical practice. Our goal is to use this information to develop improved standards of care through the NHMRC Centre of Excellence in Severe Asthma.

This survey consists of 15 questions and we anticipate it will take less than 10 minutes to complete.

If respondents can submit their responses by Friday 02 November 2018 it will be greatly appreciated.

Thank you and kind regards,

Profs. Peter Gibson, Vanessa McDonald and John Upham, on behalf of the Centre of Excellence in Severe Asthma

This survey has been approved by the HNELHD HREC under authorisation number AU201809-09. All responses are completely anonymous and will be kept strictly confidential. If you experience any issues or have any questions, please contact: severeasthma@newcastle.edu.au

 

Management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics

Dear TSANZ Member,

You are invited to participate in a survey that is being conducted as part of a research study. The following survey asks a series of questions about your current practice, specifically with regards to the management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics. Insights gained will be considered for future presentation and publication. The estimated time to complete the survey is 10 minutes. Partial responses will not be saved if you exit out the survey early. Your participation is voluntary and anonymous. Responses will be kept confidential. Your contribution is greatly appreciated.

The survey can be completed here: https://hms.az1.qualtrics.com/jfe/form/SV_8ddQsXRFwaqAtPD 

If you have any questions about the survey, please contact the study team at: vholden@som.umaryland.edu

We thank you in advance for your participation.

Sincerely,

Van Holden, MD
Mihir Parikh, MD
Alex Chee, MD
Adnan Majid, MD

Division of Thoracic Surgery & Interventional Pulmonology
Beth Israel Deaconess Medical Center
Harvard Medical School

The attached survey has been approved by the Beth Israel Deaconess Institutional Review Board – The IRB Protocol # is 2018P000052.

 

Centre for Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT)

ANZ health professionals who care for people with lung cancer are invited to take part in a survey about the clinical importance and management of cough.

Cough in lung cancer – a health professional survey

The survey link is: https://www.surveymonkey.com/r/cough_in_lung_cancer

Survey results will be used to establish the need and direction for development of further pharmacological and non-pharmacological management strategies for cough in lung cancer.

We are interested in the views of health professionals from the full range of disciplines, specialties and settings involved in caring for people with lung cancer, regardless of their level of experience in managing cough.

Participation in the survey is voluntary and anonymous, and will take approximately 10-15 minutes.

This project is being conducted by a team of researchers from the University of Technology Sydney (UTS) in collaboration with colleagues at the Hong Kong Polytechnic University (HKPU).

For more information, please contact Dr Tim Luckett via tim.luckett@uts.edu.au or 02 9514 4861.

 
 
 
 
 

.

WHY JOIN US?

Become part of a network of professionals working in respiratory and lung health clinical care and treatment, research, health promotion and advocacy.

By browsing our website you agree to our use of cookies outlined in our revised Privacy Policy and Terms & Conditions.

X